Mutations in SF3B1 have been identified at a relatively high frequency in some tumors, such as hematologic malignancies, uveal melanoma (UM), and breast cancers (BC) (Ellis et al. 2012; Banerji et al. 2012; Cazzola et al. 2013). This evidence concerns the gene SF3B1 and hematologic disorder.